BPC-157: Benefits, Side Effects and How to Buy It Legally

How is BPC-157 thought to work?

Most of what is known about BPC-157 comes from cell and animal research, not large human trials. In those studies it is described as supporting angiogenesis (the growth of new small blood vessels), which can bring more blood flow to an injured area, and as influencing growth-factor signaling involved in repair. Researchers have also looked at its effects on the gut lining and on tendon cells. Because human data is still limited, these mechanisms should be considered promising but unproven in people.

BPC-157 side effects

BPC-157 has never been through a large human trial, so its side-effect rate is not known. The handful of small human reports and user surveys most often describe mild, short-lived problems:

• Redness, itching, a small bump or pain where it was injected
• Nausea, cramps or loose stools in the first days
• Lightheadedness, flushing or a brief drop in blood pressure
• Headache or tiredness

A 2025 pilot study gave BPC-157 by IV infusion to two healthy adults and reported no adverse effects on their vital signs or blood tests, but two people cannot show long-term safety.

The bigger open question is cancer. BPC-157 helps grow new blood vessels in animal studies, and tumors also rely on new blood vessels, so people with active cancer or a history of cancer are usually told to avoid it. No human study has shown that it causes or speeds cancer, and none has ruled it out. Call your provider about swelling, a hot or spreading area around the injection site, fever, or dizziness that does not pass.

BPC-157 injection vs. oral capsules and nasal spray

Prescription BPC-157 is usually compounded as an injection given under the skin (subcutaneous), often near the area being treated or in the belly. Oral capsules are also sold, because BPC-157 is unusually stable in stomach acid, but there is far less evidence that a swallowed dose reaches tendons or joints. Treatment is typically prescribed for a set number of weeks rather than indefinitely. BPC-157 nasal sprays are also sold online, with even less evidence behind them. Prescription BPC-157 from Rx.com is the injectable form.

Your provider chooses the form, dose and schedule, and the pharmacy label on your prescription lists them. Do not copy doses from forums or research-chemical sellers.

BPC-157 dosage

There is no FDA-approved dose of BPC-157, and no large trial has set one. Below is what providers commonly prescribe and what the few human studies used.

• Common prescribed range: 250 to 500 mcg injected under the skin once a day (sometimes split into two doses), in courses of about 4 to 12 weeks. A 2026 orthopaedic review describes 200 to 1,000 mcg a day and notes there is no consensus.
• In human studies: about 4 mg injected once or twice into the knee joint (16 patients), 10 mg injected into the bladder wall once (12 patients with interstitial cystitis), and 10 mg then 20 mg by IV over two days in a 2-person safety pilot.
• What the evidence is: the everyday range is a practice convention based on animal studies. FDA's July 2026 review found no human studies of BPC-157 given under the skin, by mouth or as a nasal spray.

Your provider sets your dose, schedule and course length based on your health, goals and other medicines. Do not change your dose on your own.

What human studies have found

Almost all BPC-157 research is in rats and cells, mostly from one group in Croatia, where it sped healing of tendons, ligaments, muscle, the stomach lining and blood vessels. Human data are thin: a 2021 retrospective report found most of 16 patients given knee injections said their pain improved, and the 2025 IV pilot above. There are no randomized, placebo-controlled trials.

A 2025 review in Current Reviews in Musculoskeletal Medicine summed it up: promising animal results, but not enough human evidence to call it safe or effective. That is the honest state of the science today.

BPC-157 and TB-500 (the "Wolverine stack")

Online, BPC-157 is often discussed with TB-500 as the "Wolverine stack." No study has tested the two together in people. Rx.com's BPC-157 is a single-ingredient prescription and is not combined with any other peptide. Read more in our Wolverine stack guide.

Frequently asked questions